|
Federal
Register Notices > Notice of
Application 2006 >
Cerilliant API Services, LLC
FR Doc E6-4302 [Federal Register: March 24, 2006 (Volume 71, Number 57)]
[Notices] [Page 14948] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24mr06-109]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations
(CFR),
this is notice that on June 13, 2005, Cerilliant API Services, LLC, 811 Paloma
Drive, Suite A, Round Rock, Texas 78664, made application to the Drug
Enforcement Administration (DEA) for registration as a bulk manufacturer of the
basic classes of controlled substances listed in Schedule I and II; and by
letter dated September 2, 2005, to modify its name to Austin Pharma, LLC.
|
Drug
|
Schedule
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinois (7370)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
Psilocyn (7438)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Benzylmorphine (9052)
|
I
|
|
Codeine-N-oxide (9053)
|
I
|
|
Cyprenorphine (9054)
|
I
|
|
Desomorphine (9055)
|
I
|
|
Etorphine (9056)
|
I
|
|
Codeine methylbromide (9070)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Hydromorphinol (9301)
|
I
|
|
Methyldihydromorphine (9304)
|
I
|
|
Morphine methylbromide (9305)
|
I
|
|
Morphine-N-oxide (9307)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Normethadone (9635)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Poppy Straw Concentrate (9670)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Remifentanil (9739)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Carfentanil (9743)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
Any other such applicant and any person who is presently registered with DEA
to manufacture such a substance may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail may be
addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL);
or any being sent via express mail should be sent to DEA Headquarters,
Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis
Highway, Alexandria, Virginia 22301; and must be filed no later than May 23,
2006.
Dated: March 20, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-4302 Filed 3-23-06; 8:45 am]
BiLLiNG CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
